“…Genetic mouse model for Described in Behavioral phenotype of mutant mice EGF-like domain Nrg1 (heterozygous) Background: C57BL/6 (Michailov et al, 2004) -developed by (Meyer & Birchmeier, 1995) WT-like performance in bar test and rotarod EGF-like domain Nrg1 (heterozygous) Background: C57BL/6 ϫ 129/SVEV (Gerlai et al, 2000;Stefansson et al, 2002) developed by (Erickson et al, 1997) Hyperactivity in OF but no impaired habituation, WT-like SA, improved rotarod performance, 16% fewer functional NMDA receptors Transmembrane domain Nrg1 (heterozygous) Background: C57BL/6 (Boucher et al, 2007a(Boucher et al, , 2007bKarl et al, 2007;O'Tuathaigh C et al, 2007;O'Tuathaigh C et al, 2006;Stefansson et al, 2002) developed by (Stefansson et al, 2002) Clozapine-reversible hyperactivity in OF, impaired habituation to novelty, reduced anxiety, moderate PPI deficits, WT-like spatial memory and SA, impaired response to social novelty, increased aggression; elevated susceptibility to EE and the neurobehavioural effects of ⌬ 9 -THC -age-dependent and sexually dimorphic phenotype Immunoglobulin-like domain Nrg1…”